Format

Send to

Choose Destination
See comment in PubMed Commons below
J Drugs Dermatol. 2007 Mar;6(3):337-9.

Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient.

Author information

1
Department of Dermatology, University Hospital U.A.N.L. Dr. Jose Eleuterio González, Monterrey, Nuevo León, Mexico.

Abstract

Pityriasis rubra pilaris has no single effective therapy and there are some cases resistant to multiple treatments. Psoriasis has clinical and therapeutic response overlaps with pityriasis rubra pilaris and there are several therapies common to both, such as retinoids, methotrexate, cyclosporine A, phototherapy, and most recently infliximab. We report a case of a 10-year-old boy with pityriasis rubra pilaris unresponsive to topical corticosteroids, salicylic acid, pimecrolimus, calcitriol, calcipotriol, ultraviolet B targeted phototherapy, isotretinoin, systemic PUVA, acitretin, and etanercept. He was treated with efalizumab 1 mg/kg weekly and a successful outcome was obtained with a 50% improvement after the first dose. The patient remains in remission after 9 months of treatment.

PMID:
17373198
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center